Streetbeat News

Analyst Ratings

PRAA

JMP Securities analyst David Scharf has maintained a Market Outperform rating on PRA Group (NASDAQ:PRAA) and increased the price target from $26 to $33.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:55 pm

PCOR

JMP Securities analyst Joe Goodwin has maintained a Market Outperform rating on Procore Technologies (PCOR) and increased the price target from $81 to $93.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:50 pm

OPEN

JMP Securities analyst Nicholas Jones has maintained a Market Outperform rating on Opendoor Technologies (NASDAQ:OPEN) but has lowered the price target from $5 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:48 pm

MDGL

JMP Securities analyst Jonathan Wolleben has reiterated a 'Market Outperform' rating on Madrigal Pharmaceuticals (MDGL) and maintained a price target of $347.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:46 pm

TMUS

Deep-pocketed investors have shown a bearish sentiment towards T-Mobile US (NASDAQ:TMUS), with options trading data revealing 80% bearish and 20% bullish positions. The trading activity suggests a price target range of $160.0 to $220.0. Currently, TMUS's stock is slightly down by -0.15%, trading at $161.33, with an average analyst price target of $190.2. The company, a major player in the U.S. wireless market, has seen significant options activity, indicating potential market movements.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:46 pm

DASH

JMP Securities analyst Andrew Boone has reiterated a 'Market Outperform' rating on DoorDash (NASDAQ:DASH) and maintained a $130 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:41 pm

COIN

JMP Securities analyst Devin Ryan has maintained a Market Outperform rating on Coinbase Global (NASDAQ:COIN) and increased the price target from $200 to $220.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:39 pm

BPMC

JMP Securities analyst Reni Benjamin has reiterated a Market Outperform rating on Blueprint Medicines (NASDAQ:BPMC), maintaining a price target of $114.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:36 pm

SAVE

Significant options trading activity has been observed for Spirit Airlines (NYSE:SAVE), indicating a predominantly bullish market sentiment among big-money investors. Benzinga's options scanner revealed 8 notable trades, with a split of 87% bullish and 12% bearish sentiment. The trading activity focuses on a price band between $5.0 and $30.0 for SAVE, with a mix of puts and calls indicating diverse strategies. The current market status of Spirit Airlines shows a slight decrease in stock price, with an RSI suggesting it may be approaching overbought territory. Analysts have a bearish outlook, with an average target price of $4.0 and Citigroup downgrading SAVE to Sell.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:30 pm

AZN

Financial giants have shown a bearish trend on AstraZeneca (NASDAQ:AZN) with 61% of options trades indicating bearish sentiment. Analysis of options history revealed 13 unusual trades, with a focus on a price band between $50.0 and $77.5. The trading volume and open interest suggest significant market activity. AstraZeneca's stock is currently up by 1.53%, with a trading volume of 5,108,125 and an RSI indicating a neutral position.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:30 pm